This message was sent to ##Email##
March 19-22, 2020
San Antonio Marriott Rivercenter
101 Bowie Street - San Antonio, Texas
The ADAA 2020 40th Annual Conference (March 19-22, San Antonio, TX) will bring together an expected 1,400 clinicians and researchers from across the US and around the world who want to improve treatments and find cures for anxiety, depression, and co-occurring disorders. Choose from 160+ sessions, hear engaging plenary speakers, learn about cutting-edge thinking in research and clinical practice, and earn CEs and CMEs.
- Understand the meaning of resilience, as demonstrated through translational models, human subjects research, and clinical applications.
- Identify the genetic, epigenetic, neurobiological, developmental, and psychosocial underpinnings of resilience.
- Be exposed to preventive and treatment interventions aimed at enhancing resilience across the life span.
Special #ADAA2020 Events
- Opening Session and Keynote Address
- Jerilyn Ross Lecture
- Scientific Research Symposium
- Clinical Practice Symposium
- Master Clinician Sessions
- Science Spotlight
- Main Stage Event! Celebrating ADAA’s 40th Anniversary
Don’t miss out on early bird registration rates: register now! ADAA members enjoy a significant discount on registration fees. Make sure you sign up before December 1, 2019 to get the lowest registration rate of the conference.
Main Stage Event – ADAA is Turning 40!
Plan now to stay through Saturday night to help ADAA celebrate our 40th Anniversary at the Marriott Rivercenter. This festive evening will feature live entertainment, awards recognition, tributes to our longtime ADAA members, a memorable culinary experience, opportunities to meet and network with ADAA members and peers, and more.
#ADAA2020 Hotel Information
The San Antonio Marriott Rivercenter - #ADAA2020 Conference Hotel |
The 2020 ADAA Annual Conference (March 19-22) will be held at the San Antonio Marriott Rivercenter (101 Bowie Street, San Antonio, TX 78205) on the San Antonio River. Conference activities, including all sessions, exhibits, and receptions, take place at the San Antonio Marriott Rivercenter, which will be newly renovated in February. Plan to be there Saturday night (March 21) to help ADAA celebrate our 40th Anniversary!
Special ADAA Rate: $229
La Quinta San Antonio Riverwalk|
La Quinta is located directly across the street from the headquarters hotel and a one-minute walk to the conference rooms at the Marriott Rivercenter. A complimentary breakfast is provided for overnight guests.
Special ADAA Rate: $199
Please reserve your room prior to February 24, 2020.
Thank you to our Current #ADAA2020 Supporters
American Foundation for Suicide Prevention
BECK Cognitive Behavior Therapy
Cohens Veterans Network
Collaborating with ADAA provides an opportunity to reach ADAA’s vast network of psychiatrists, social workers, psychologists, counselors, and therapists before, during, and after the conference. Invest in your customer relationships and make an impact. Interested in sponsoring at #ADAA2020? Please contact Lise Bram.
American Foundation for Suicide Prevention
BECK Cognitive Behavior Therapy
Lido Wellness Center
Mountain Valley Treatment Center
Renewed Freedom Center
We invite you to join 1,400+ US and global leaders and experts in mental health and to engage with 400-500 new exhibit hall visitors daily. The Partner Solutions Hall is the center of the conference – on the same floor as all session rooms – it's the place to be! The Partner Solutions Hall will host many activities, including the Welcome Reception and Hall Grand Opening, reboot breaks, and more. Come help us celebrate our 40th Anniversary. Please contact Lise Bram for more information about exhibiting.
|ADAA Professional Education
ADAA offers a variety of webinars for mental health professionals. Most ADAA professional webinars offer CE/CME and AWSB credits. Sign up today to make sure you don’t miss out on these educational opportunities.
REGISTER NOW! - Thursday, November 7, 2019 – Julie Wetherell, PhD, ABPP
State of the Science: Interventions for Anxiety in Older Adults
Eligible for 1 CE/CME credit
Recent On-Demand Webinars
Just added: Spotlight on Maternal Mental Health: Treatment and Research
Presented by Joy Burkhard, MBA; Catherine Monk, PhD; Margaret Altemus, MD; and Rahil Briggs, PsyD
Eligible for 3 CE/CME hours
(This webinar is not eligible for NBCC credit.)
Complicated Grief and Its Treatment
Eligible for 1 CE/CME credit
by Katharine Shear, MD
Interested in presenting a professional webinar? Click here to download the ADAA Webinar Interest Form or contact Astrid Masfar (email@example.com)
Personal Stories of Triumph - Supporting ADAA’s Mission
ADAA shares stories of triumph submitted by our public community that focus on how people living with anxiety, depression, obsessive-compulsive, and trauma-related disorders have struggled, coped, and triumphed.
Over the summer, Kennedy shared her story with ADAA.
“In 2018 I founded Arts for Anxiety, a confidence building movement that encourages people who suffer from anxiety to use the arts to help them with their symptoms. For more than a year I have been travelling throughout New England to share my story and encourage others to use the Arts to overcome their anxiety. I perform for hospitalized children and veterans so that my music can be part of their healing from anxiety-provoking situations.”
Click here to read Kennedy's full story and to read other ADAA personal stories.
ADAA Member News
ADAA Congratulates Scott Rauch, MD on Election to National Academy of Medicine
On October 23, 2019 ADAA Board Secretary Scott Rauch, MD of McLean Hospital was elected to the National Academy of Medicine (NAM).
Offered to approximately 80 professionals in the fields of health and medicine a year, election to the NAM is considered one of the highest honors recognizing individuals who have demonstrated outstanding professional achievement.
In the announcement, NAM President, Victor J. Dzau, stated, "These newly elected members represent the most exceptional scholars and leaders whose remarkable work has advanced science, medicine, and health in the U.S. and around the globe. Their expertise will be vital to addressing today's most pressing health and scientific challenges and informing the future of health and medicine for the benefit of us all."
ADAA also recognizes its other members elected to the NAM:
- Larry Culpepper, MD
- Daniel Pine, MD
- Judy Garber, PhD
- Kerry Ressler, PhD
- Ned Kalin, MD
- Alan Schatzberg, MD
- Ronald Kessler, PhD
- Myrna Weissman, PhD
- David Kupfer, PhD
- Charlie Nemeroff, MD, CMO and ADAA board member
ADAA Congratulates Thomas Ollendick, PhD on Lifetime Achievement Award from the Academy of Cognitive and Behavioral Therapies
Congratulations to ADAA member Thomas Ollendick, PhD who will be honored with the Academy of Cognitive and Behavioral Therapies Lifetime Achievement Award on Thursday, November 21. This prestigious award honor one individual each year who has made significant and enduring contributions to the field of cognitive therapy.
Dr. Ollendick is a University Distinguished Professor in Clinical Psychology and Director of the Child Study Center at Virginia Polytechnic Institute. He is the author or co-author of over 350 research publications, more than 100 book chapters, and 38 books.
ADAA also recognizes its other members awarded this prestigious lifetime achievement award:
- David H. Barlow, PhD (2005)
- Judith Beck, PhD (2009)
- Michelle Craske, PhD (2013)
- Richard Heimberg, PhD (2001)
- Stefan Hofmann, PhD (2015)
- Sabine Wilhelm, PhD (2018)
Mark H. Pollack, MD Named Chief Medical Officer of Myriad Neuroscience
Myriad Genetics, Inc. announced that it has named Mark H. Pollack, M.D., chief medical officer of Myriad Neuroscience effective Jan. 15, 2020. In this role, Dr. Pollack will lead efforts to make GeneSight standard-of-care in clinical practice.
“We are excited to welcome Dr. Pollack to Myriad. During his distinguished clinical career, Dr. Pollack has been on the forefront of medical advances in treating people with mood and anxiety disorders,” said Mark Verratti, president of Myriad Neuroscience. “He is joining us at a pivotal time when we’re working to expand access to the GeneSight test and ushering in a new era of precision medicine for people with mental illness.”
Dr. Pollack is a board-certified psychiatrist with more than 30 years of experience in clinical psychiatry and neuroscience. Most recently, he served as professor and chair of the Department of Psychiatry at Rush University Medical Center in Chicago. Prior to Rush, Dr. Pollack was a professor of psychiatry at Harvard Medical School and director of the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital. He is an ADAA past president and served as chairman of its Scientific Advisory Board. Dr. Pollack is recognized worldwide as an expert on mental illness, lectures widely in national and international forums and has served on numerous editorial, federal and industry advisory boards to advance the field of psychiatry. He has published extensively including more than 300 journal articles, five books and 39 book chapters.
Krystal M. Lewis, PhD
“My graduate school advisor, Thomas H. Ollendick, encouraged his students to join ADAA and doing so was such a great decision. ADAA has been my professional home since 2008 and during that time I have presented posters and talks at the annual conferences, participated in the Career Development Leadership program (CDLP), co-chaired Special Interests Groups (SIG), mentored with the CDLP, and volunteered to help with several other endeavors. ADAA is an amazing organization and a provides great opportunities for young professionals to volunteer, network, and experience immense professional growth. I’m excited to continue working with ADAA as my own professional goals align nicely with the organizations mission.”
“I really enjoy the collaboration with professionals around the country. ADAA provides an opportunity to learn about research by attending talks at the conference, participating in webinars, and reading about new insights via email or social media. I especially enjoy the relationships that have developed from participating with the different SIGs. The Child and Adolescent SIG has monthly peer consultation calls which allows us to engage with specialists within our organization and obtain clinical consultation for challenging, unique cases. It’s a space for clinicians at all stages of development to talk with one another, share insightful tips and tools, and be part of a community of providers who are passionate about providing the best clinical care to children and adolescents.”
“Being an active ADAA member contributes to my work in a variety of ways. I have at hand a group of professionals whom I can call on when I need clinical advice, researchers who I can collaborate with on projects or involve in SIG meetings to present their work, and a professional home where I feel most comfortable. I encourage students and trainees to join this organization which will contribute to their professional growth and maintain their excitement about their work.”
About Dr. Lewis:
Krystal M. Lewis, PhD is a clinical psychologist who works with children and adolescents at the National Institute of Mental Health. She provides Cognitive Behavioral Therapy to youth participating in a pediatric anxiety study. Dr. Lewis specializes in evidence-based treatments including cognitive behavior therapy and exposure therapy for anxiety. She also has a small private practice where she provides services to children and adults. Dr. Lewis is invested in helping parents, teachers, and those who work with youth to better identify signs and symptoms of anxiety in youth and works to ensure that the effective practices are being used to prevent and treat anxiety. She gives talks around the community to disseminate best practices for child anxiety.
We encourage all of our new members to join the new ADAA online member community, SocialLink, today to start connecting!
ADAA Member Benefit Alert!
Did you know that ADAA members receive complimentary access to the ADAA Journal Depression and Anxiety? Depression and Anxiety, the official online journal of the Anxiety and Depression Association of America, welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.
If you have questions about ADAA member benefits, email us at firstname.lastname@example.org.
New ADAA Member Public Blog Post
Long-Term Use of Benzodiazepines – Avoiding Another Drug Crisis
by Mark A. Smith, MD, PhD
This blog post is presented by the ADAA 2020 Conference Gold Sponsor VistaGen Therapeutics.
Barn Life Recovery is dedicated to the prevention and treatment of anxiety, depression, PTSD, and co-occurring disorders through our intensive outpatient and day programs. At our holistic recovery center, our staff encourages evidence-based healing practices (synthetic-free psychology, relapse prevention, meditation, Tai Chi, and martial arts) within an idyllic setting. Let’s partner and change lives together.
|ADAA Members in the Media — Recent Articles
Have you been quoted in a recent news article/story? Please let us know so we can share your news with your ADAA colleagues and with our public community (here, through the website and via our social media platforms).
11/1/2019 Is Anxiety More Common in Our 30s and 40s?, TheGuardian.com, Kevin Chapman, PhD
10/30/2019 Checking Your Phone When You First Wake Up Doesn’t Have To Be Bad, Bustle.com, Debra Kissen, PhD, MHSA
10/29/2019 Have You Heard of Trypophobia?, Shape.com, Martin Antony, PhD and Stephanie Woodrow, LCPC, NCC
10/29/2019 Narcissists Are Less Likely To Get Depression, Psychologists Believe, NewsWeek.com, Stephanie Kriesberg, PsyD
10/29/2019 How To Help A Child Struggling With Anxiety, NPR.org, Krystal Lewis, PhD and Daniel Pine, MD
10/29/2019 ADAA Congratulates Scott Rauch, MD on his election to the National Academy of Medicine
10/28/2019 When the Prescription for Teens Is More Social Media, not Less, WSJ.com, Anne Marie Albano, PhD, ABPP and Shane Owens, PhD, ABPP
10/27/2019 What is a “Sticky Mind”? Here’s How to Deal With the Symptom of Anxiety That Could be Triggered by Reading the News, Stylist.co.uk, Sally Winston, PsyD and Martin Seif, PhD, ABPP
10/23/2019 Summer Walker’s Battle With Social Anxiety Is A Teachable Moment For Fans And Critics, BET.com, Angela Neal-Barnett, PhD
10/22/2019 Depression Rates Not Budging for Lesbian and Gay Teens, MedicalXpress.com, Alexandra Bettis
October 2019 Coping Skills For Anxiety, The Therapycast, James Cowart, PhD
10/20/2019 If You're An Obsessive Compulsive Thinker, You May Notice These Thought Patterns, Bustle.com, Stephanie Woodrow, LCPC, NCC
10/19/2019 Women are more than twice as likely as men to suffer from PTSD. Studies are underway to find out why., Washington Post, Edna Poa, PhD
10/18/2019 Where is my Xanax Rx? Why Your Doctor may be Concerned about Prescribing Benzodiazepines, TheConversation.com, Arash Javanbakht, MD
10/18/2019 On Overcoming the Fear of Flying, Avpress.com, Martin Seif, PhD, ABPP
10/17/2019 Fear of the Unknown, BootUp, Posting Tantrums, Self-Care for Empaths, Pregnancy and Infant Loss, Finance for Young People, BYURadio.org, Simon Rego, PsyD
10/17/2019 Clinical Challenges: Treatment Combinations for Depression, MedPageToday.com, Michael Thase, MD
10/17/2019 CDC Finds Rising Suicide Rates For Young People, NPR.org, Jill Harkavy-Friedman, PhD
ADAA Member News & Publications
Have you published a new book for consumers or professionals? Please let us know so we can highlight your new publication here and on the ADAA website.
ADAA is also interested in highlighting our members' research. Please send us your recent research news for us to post and share.
Overcoming Anxiety and Panic Interactive Guide
by Elizabeth McMahon, PhD
Dr. McMahon is offering a FREE REVIEW COPY to the first 20 licensed psychotherapists who email her their name and mailing address: Elizabeth@Elizabeth-McMahon.com.
The ABCs of Coping with Anxiety: Using CBT to manage stress and anxiety
by James Cowart, PhD
|Depression and Anxiety Journal News
Volume 36, Issue 10
FOCUS ON: Depression, Suicidality and Health
Mood and suicidality outcomes 3–11 years following pediatric anxiety disorder treatment
Courtney P. Keeton PhD, Nicole E. Caporino PhD (ADAA Member), Philip C. Kendall PhD, ABPP Satish Iyengar PhD, Phyllis Lee PhD, Tara Peris PhD, Dara Sakolsky MD, PhD (ADAA Member), John Piacentini PhD, ABPP (ADAA Member), Scott N. Compton PhD, Anne Marie Albano PhD, ABPP, (ADAA Member), Boris Birmaher MD, Golda S. Ginsburg PhD (ADAA Member)
Is there a relationship between chocolate consumption and symptoms of depression? A cross‐sectional survey of 13,626 US adults
Sarah E. Jackson, Lee Smith, Joseph Firth, Igor Grabovac, Pinar Soysal, Ai Koyanagi, Liang Hu, Brendon Stubbs, Jacopo Demurtas, Nicola Veronese, Xiangzhu Zhu, Lin Yang
Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: A nationwide cohort study
Gal Shoval, Ran D. Balicer, Becca Feldman, Moshe Hoshen, Gilad Eger, Abraham Weizman, Gil Zalsman, Brendon Stubbs, Pavel Golubchik, Barak Gordon, Amir Krivoy
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online at no charge to ADAA members. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans. Per the ISI Journal Citation Reports Rankings for 2017, the Depression and Anxiety impact factor is 5.043. The journal ranks 19 of 142 in psychiatry journals; 8 of 77 in psychology journals; 5 of 121 for psychology clinical journals, and 15 of 139 for psychiatry social science journals. Google Scholar psychiatry journal ranking (spring 2017) ranked Depression and Anxiety #19 of 20.
Murray B. Stein, MD, MPH - Editor-in-Chief
Meet the Journal Editorial Board
Interested in submitting an article? View the Depression and Anxiety Submissions Guidelines.
New BrainsWay Webinar Opportunity
“A New Era in OCD Treatment: Clinical Evidence for Deep TMS”
In addition, BrainsWay is hosting a unique lunch education session at the esteemed Neuroscience Education Institute (NEI) Congress on Friday, November 8, 2019 in Colorado Springs, CO. This session will give providers a chance to share their insights and help answer questions on how they have successfully implemented dTMS technology in their practices. For more details and to register, visit https://www.go.brainsway.com/NEICongressSymposium. The session will feature presentations by Dr. Aron Tendler (Advanced Mental Healthcare); Dr. Manish Sheth (Achieve TMS); Dr. Amanda Itzkoff (Amanda Itzkoff, MD); and Dr. Hy Gia Park (Arahant Mental Wellness).
Mental Health America Accepting Proposals for Annual Conference
Mental Health America is accepting proposals for their 2020 Annual Conference. MHA’s 2020 Annual Conference: From Resiliency to Recovery will take place in Washington, DC on June 11-13, 2020. MHA’s conference brings together hundreds of MHA affiliates, peers, providers, government officials, media and more from across the country to discuss important and emerging mental health issues.
To submit, please review MHI’s Call for Proposals. Sample presentation titles, content we are interested in exploring, and more is available on the website: https://www.mhanational.org/2020/annual-conference/call-workshop-proposals. The deadline for submissions is November 29, 2019.
Webinar on Virtual Reality and Anxious Youth
Tuesday, November 12, 2019, 2:00 pm EST
Brain & Behavior Research Foundation is presenting a webinar entitled Integrating Virtual Reality into Psychotherapy for Anxious Youth featuring Michelle Pelcovitz, PhD. The most common age of onset for anxiety disorders is in adolescence and young adulthood and can put youth at risk for failure to meet academic, social, and occupational milestones, or for developing depression and substance use if not properly treated. Cognitive behavioral therapy with exposure therapy has been identified as the frontline treatment, however a substantial number of patients do not get better or experience relapse. Dr. Pelcovitz will discuss her current research, focusing on enhancing existing therapies by integrating cutting edge technology. Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
We Love Our Facebook Fundraisers
You and your Facebook friends can support causes that are important to you (like ADAA) by raising funds and awareness right on Facebook.
Read more and start your own fundraiser today.
Calling all gamers and live streamers!
You can reach new audiences and help raise awareness about ADAA's mission by creating a fundraising stream (or encouraging you friends to create a campaign or donate) on Tiltify.com that benefits ADAA's mission.
Shop Amazon Smile and Support ADAA
Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to the charity of your choice. AmazonSmile is the same Amazon you know. Same products, same prices, same service. Select ADAA on AmazonSmile and support our work with every item you purchase. Shop today.
Fun ADAA Merch
Buy a gift for yourself and a loved one and support ADAA at the same time. Proceeds support ADAA's mission to provide free resources to those struggling with anxiety, depression, and co-occurring disorders. Shop ADAA's Store.
| || RESEARCH AND PRACTICE NEWS|
In the October 2019 issue of Contemporary Pediatrics, Dr. Michael Shapiro looks at depression in preschool aged kids. For many in pediatrics, depression and other related diagnoses can present a challenge.
The Wall Street Journal
Psychologists have a new directive for anxious teens: Post selfies on Instagram and Snapchat.
Most teens, it can seem to grown-ups, need to be pulled away from social media. Teens with anxiety disorders, however, may need to be pushed toward it.
The Lancet via ScienceDaily
The most comprehensive analysis of medicinal cannabinoids and their impact on six mental health disorders — combining 83 studies including 3,000 people — suggests that the use of cannabinoids for mental health conditions cannot be justified based on the current evidence. This is due to a lack of evidence for their effectiveness, and because of the known risks of cannabinoids.
University of British Columbia via ScienceDaily
New research published in JAMA Psychiatry shows for the first time that patients with mood and anxiety disorders share the same abnormalities in regions of the brain involved in emotional and cognitive control.
The findings hold promise for the development of new treatments targeting these regions of the brain in patients with major depressive disorder, bipolar disorder, posttraumatic stress disorder, and anxiety disorders.
Mindfulness meditation supplemented with psilocybin may produce synergistic effects and potentially counteract symptoms of several mental disorders, including depression, according to findings published in Scientific Reports.
HealthDay News via U.S. News & World Report
Smoking is a notoriously tough habit to quit, but a new study suggests it is far harder for women to stop than it is for men.
Why? The researchers point to a higher prevalence of anxiety and depression in women, which might interfere with even the best intentions to kick the habit. And one expert noted that prior evidence has shown that women's brains react differently to nicotine.
The majority of older adults with depression have high levels of disability over time, according to results published in European Psychiatry. The study included older participants aged at least 60 years with and without depression. The researchers used The World Health Organization World Mental Health Composite International Diagnostic Interview to assess depressive disorders at baseline and follow-up.
Researchers in the United States and Switzerland have identified neural subcircuits and genetic biomarkers in mice that are linked with a common symptom of depression. The studies, headed by a team at the University of California, Berkeley, identified the gene targets for treating lack of motivation in a mouse model of depression, and say that the findings could provide a springboard for the discovery of biomarkers for other defined symptoms of depressive disorders, and so the development of targeted, precision medicine.
In comparison with their native peers, children and adolescents with a Turkish migration background showed notable differences in psychological disorders, according to study results published in Child and Adolescent Psychiatry and Mental Health.
Anxiety and depression in patients with cancer are associated with increased pain intensity, according to a study presented at the Supportive Care in Oncology Symposium.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063